From: Salivary microbiome profiles of oral cancer patients analyzed before and after treatment
Baseline | Follow-up | Difference between timepoints | |
---|---|---|---|
Sexa, male (%) | 15 (54%) | ||
Mean age, years (SD) | 65.7 (10.3) | 69.8 (10.3) | |
Smokers (%) | 11 (39%) | ||
Alcohol users (%) | 20 (71%) | ||
Edentate (%) | 1 (4%) | 4 (14%) | NS |
Mean SFR, ml/min (SD) | 1.1 (0.6) | 0.8 (0.6) | p = 0.0008 |
Dry mouth, SFR < 0.5 ml/min (%) | 4 (14%) | 10 (36%) | NS |
Mean concertation of bacterial DNA, 16S qPCR, ng/μl (SD) | 2.7 (2.3) | 2.3 (2.7) | NS |
Candidiasisb (%) | 11 (39%) | 19 (68%) | p = 0.03 |
Mean Candida concentration, log10[CFU/ml] (SD) | 2.3 (1.3) | 2.9 (1.3) | NS |
Mean concentration of yeasts, 28S qPCR, ng/μl (SD) | 0.0049 (0.008) | 0.0093 (0.02) | NS |
Tumor class c | |||
T1 (%) | 19 (68%) | ||
T2–T4 (%) | 9 (32%) | ||
Stagec | |||
I–II (%) | 18 (64%) | ||
III–IV (%) | 10 (36%) | ||
Treatment | |||
Excision with direct wound closure (%) | 5 (28%) | ||
Reconstructive surgery (%) | 11 (39%) | ||
Reconstructive surgery + radiation therapy (%) | 11 (39%) | ||
Reconstructive surgery + chemoradiation therapy (%) | 1 (4%) |